Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc.

The tremendous momentum of state legalization of medical-use cannabis in the United States has led to a transformation in the way patients can obtain treatment for a wide spectrum of medical conditions in a safe, reliable and compassionate environment, giving hope to millions. Our focus is to partner with well-capitalized, experienced medical-use cannabis growers in states with a robust medical-use regulatory environment. Our acquisition strategy is to act as a source of capital to these licensed medical-use cannabis growers by acquiring and leasing back their real estate locations. By selling the real estate to us, and then leasing it back, growers have the opportunity to redeploy the proceeds into their company’s core operations allowing them to focus their resources on reaching as many patients as possible in need of treatment.
1d 5d 1m 6m 1y Max

Innovative Industrial Properties Inc. News

25 Jun

Will Innovative Industrial Properties Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Innovative Industrial Properties.

24 Jun

Innovative Industrial (IIPR) Acquires Property in Michigan

Expansion of portfolio in Michigan and lease with Emerald Growth Partners to help Innovative Industrial Properties (IIPR) bank on the favorable trends and achieve top-line growth.

22 Jun

Here's Why This REIT Could Be the Best Cannabis Stock You've Never Heard Of

Being a landlord might not seem exciting, but rapidly rising dividends should get everyone's attention.

21 Jun

Why Innovative Industrial Properties, Korn Ferry, and Sprint Slumped Today

Nervous reactions to a host of different situations sent these stocks lower.

21 Jun

Innovative Industrial Properties Expands In Michigan, Signs Lease With Emerald Growth Partners

Innovative Industrial Properties Inc (NYSE: IIPR ) announced Friday that it acquired a property in Michigan and entered into a long-term lease agreement with Emerald Growth Partners. What Happened The...

21 Jun

I Ran A Stock Scan For Earnings Growth And Innovative Industrial Properties (NYSE:IIPR) Passed With Ease

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...

21 Jun

Does Innovative Industrial Properties (NYSE:IIPR) Deserve A Spot On Your Watchlist?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...

21 Jun

Are Insiders Buying Innovative Industrial Properties, Inc. (NYSE:IIPR) Stock?

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...

21 Jun

Innovative Industrial Properties Acquires Michigan Property and Enters Into Long-Term Lease with Emerald Gr

Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (IIPR) focused on the regulated U.S. cannabis industry, announced today that it closed...

20 Jun

BTIG: Innovative Industrial Properties 'Uniquely Positioned' For Cannabis Growth

Innovative Industrial signed a new lease agreement with cannabis company Green Peak that included $18 million of growth capital, Catherwood said in a Thursday note. The REIT invested $13 million in an...

Load more

About Innovative Industrial Properties Inc.

In 1996, voters made California the first state in the United States to allow for medical-use cannabis. Over the next twenty years, medical-use cannabis programs have been adopted by over half of the United States, where over 200 million people reside. As of December 31, 2017, 29 states, plus the District of Columbia, have adopted medical-use cannabis programs. This wave of adoption by states of medical-use cannabis programs has been driven by the rapidly evolving, overwhelming acceptance of Americans for medical-use cannabis as an alternative form of treatment for patients. In fact, according to a 2017 poll conducted by Quinnipiac University, 94% of those surveyed support adults being able to use medical cannabis, if recommended by a doctor.
According to The ArcView Group, sales of legal cannabis in North America are expected to grow from $6.8 billion in 2016 to $24.5 billion in 2021, representing a 28% compound annual growth rate. States have authorized numerous medical conditions as qualifying conditions for treatment with medical-use cannabis, which may include, among others, treatment for cancer, glaucoma, HIV/AIDs, wasting syndrome, pain, nausea, seizures, muscle spasms, multiple sclerosis, post-traumatic stress disorder (PTSD), migraines, arthritis, Parkinson's disease, Alzheimer's, lupus, residual limb pain, spinal cord injuries, inflammatory bowel disease and terminal illness. The Marijuana Policy Project estimates that, as of February 2018, an estimated 2.5 million people were registered as patients in states with regulated medical-use cannabis programs.

Team

Alan D. Gold
Executive Chairman
Paul Smithers
Chief Executive Officer, President, and Director
Catherine Hastings
Chief Financial Officer, Chief Accounting Officer...
Brian Wolfe
Vice President, General Counsel and Secretary
Ben Regin
Director of Investments and Finance
Andy Bui
Controller
Gary Kreitzer
Vice Chairman
David Stecher
Director
Scott Shoemaker
MD — Director
$ 106.10
3.45%
Open:
103.56
High:
106.24
Low:
103.00
Share volume:
150.129 K
Total value:
15.64 M
Market cap:
1.184 B
Symbol:
IIPR